Skip to main content
Signal8
FMR LLC profile photo

Fmr LLC

CIK: 0000315066

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)34 (53.1%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)30 (46.9%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (7)

Structure Therapeutics Inc. logo
GPCR

Structure Therapeutics Inc.

10% Owner
Beam Therapeutics Inc. logo
BEAM

Beam Therapeutics Inc.

10% Owner
Avalyn Pharma Inc. logo
AVLN

Avalyn Pharma Inc.

10% Owner
Rallybio Corp logo
RLYB

Rallybio Corp

10% Owner
Metsera, Inc. logo
MTSR

Metsera, Inc.

10% Owner
Sana Biotechnology, Inc. logo
SANA

Sana Biotechnology, Inc.

10% Owner
Bicara Therapeutics Inc. logo
BCAX

Bicara Therapeutics Inc.

Discretionary Trading P&L

Holdings

Transaction History (64 total)

  • Structure Therapeutics Inc. logo
    GPCR

    Structure Therapeutics Inc.

    Jul 22, 2026
    Sale(S)

    American Depositary Shares

    Indirect
    1.4K shares at avg. $50.07-
  • Structure Therapeutics Inc. logo
    GPCR

    Structure Therapeutics Inc.

    Jul 22, 2026
    Sale(S)

    American Depositary Shares

    Indirect
    16.1K shares at avg. $50.07-
  • Beam Therapeutics Inc. logo
    BEAM

    Beam Therapeutics Inc.

    Jun 26, 2026
    Sale(S)
    Indirect
    251.5K shares at avg. $35.26$8.9M
  • Beam Therapeutics Inc. logo
    BEAM

    Beam Therapeutics Inc.

    Jun 25, 2026
    Sale(S)
    Indirect
    33.4K shares at avg. $35.12$1.2M
  • Avalyn Pharma Inc. logo
    AVLN

    Avalyn Pharma Inc.

    May 1, 2026
    Conversion(C)
    Indirect
    225.8K shares-
  • Avalyn Pharma Inc. logo
    AVLN

    Avalyn Pharma Inc.

    May 1, 2026
    Conversion(C)
    Indirect
    872.9K shares-
  • Avalyn Pharma Inc. logo
    AVLN

    Avalyn Pharma Inc.

    May 1, 2026
    Conversion(C)
    Indirect
    377.9K shares-
  • Avalyn Pharma Inc. logo
    AVLN

    Avalyn Pharma Inc.

    May 1, 2026
    Conversion(C)
    Indirect
    727.6K shares-
  • Avalyn Pharma Inc. logo
    AVLN

    Avalyn Pharma Inc.

    May 1, 2026
    Conversion(C)
    Indirect
    80.3K shares-
  • Structure Therapeutics Inc. logo
    GPCR

    Structure Therapeutics Inc.

    Apr 14, 2026
    Sale(S)

    American Depositary Shares

    Indirect
    16.1K shares at avg. $55.07-
  • Structure Therapeutics Inc. logo
    GPCR

    Structure Therapeutics Inc.

    Apr 14, 2026
    Sale(S)

    American Depositary Shares

    Indirect
    1.4K shares at avg. $55.07-
  • Structure Therapeutics Inc. logo
    GPCR

    Structure Therapeutics Inc.

    Jan 15, 2026
    Sale(S)

    American Depositary Shares

    Indirect
    6.5K shares at avg. $84.22-
  • Structure Therapeutics Inc. logo
    GPCR

    Structure Therapeutics Inc.

    Jan 15, 2026
    Sale(S)

    American Depositary Shares

    Indirect
    230 shares at avg. $85.04-
  • Structure Therapeutics Inc. logo
    GPCR

    Structure Therapeutics Inc.

    Jan 15, 2026
    Sale(S)

    American Depositary Shares

    Indirect
    330 shares at avg. $83.35-
  • Structure Therapeutics Inc. logo
    GPCR

    Structure Therapeutics Inc.

    Jan 15, 2026
    Sale(S)

    American Depositary Shares

    Indirect
    5.5K shares at avg. $82.10-
  • Structure Therapeutics Inc. logo
    GPCR

    Structure Therapeutics Inc.

    Jan 15, 2026
    Sale(S)

    American Depositary Shares

    Indirect
    465 shares at avg. $82.10-
  • Structure Therapeutics Inc. logo
    GPCR

    Structure Therapeutics Inc.

    Jan 15, 2026
    Sale(S)

    American Depositary Shares

    Indirect
    552 shares at avg. $84.22-
  • Structure Therapeutics Inc. logo
    GPCR

    Structure Therapeutics Inc.

    Jan 15, 2026
    Sale(S)

    American Depositary Shares

    Indirect
    20 shares at avg. $85.04-
  • Structure Therapeutics Inc. logo
    GPCR

    Structure Therapeutics Inc.

    Jan 15, 2026
    Sale(S)

    American Depositary Shares

    Indirect
    3.9K shares at avg. $83.35-
  • Structure Therapeutics Inc. logo
    GPCR

    Structure Therapeutics Inc.

    Dec 8, 2025
    Sale(S)

    American Depositary Shares

    Indirect
    709 shares at avg. $92.52-
  • Structure Therapeutics Inc. logo
    GPCR

    Structure Therapeutics Inc.

    Dec 8, 2025
    Sale(S)

    American Depositary Shares

    Indirect
    183 shares at avg. $94.00-
  • Structure Therapeutics Inc. logo
    GPCR

    Structure Therapeutics Inc.

    Dec 8, 2025
    Sale(S)

    American Depositary Shares

    Indirect
    8.3K shares at avg. $92.52-
  • Structure Therapeutics Inc. logo
    GPCR

    Structure Therapeutics Inc.

    Dec 8, 2025
    Sale(S)

    American Depositary Shares

    Indirect
    5.6K shares at avg. $94.61-
  • Structure Therapeutics Inc. logo
    GPCR

    Structure Therapeutics Inc.

    Dec 8, 2025
    Sale(S)

    American Depositary Shares

    Indirect
    16.6K shares at avg. $61.05-
  • Structure Therapeutics Inc. logo
    GPCR

    Structure Therapeutics Inc.

    Dec 8, 2025
    Sale(S)

    American Depositary Shares

    Indirect
    15.5K shares at avg. $61.45-

1-25 of 64

About FMR LLC

FMR LLC (SEC CIK 0000315066) files insider reports with the SEC as 10% Owner of Structure Therapeutics Inc. (GPCR), 10% Owner of Beam Therapeutics Inc. (BEAM) and 10% Owner of Avalyn Pharma Inc. (AVLN). Signal8 also holds filings tied to 4 other companies.

Signal8 holds 26 ownership filings by FMR LLC (6 Form 3, 20 Form 4), filed between Sep 12, 2024 and Jul 24, 2026. Those filings report 64 transactions, from Sep 16, 2024 to Jul 22, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on FMR LLC's filings is in BOSTON, MA.

Recent filings by FMR LLC

  • Jul 22, 2026: Open-market sales of GPCR derivative securities (2 lines, Form 4, code S).
  • Jun 26, 2026: Open-market sale of BEAM shares (Form 4, code S).
  • Jun 25, 2026: Open-market sale of BEAM shares (Form 4, code S).
  • May 1, 2026: Conversions of AVLN shares (5 lines, Form 4, code C).
  • Apr 14, 2026: Open-market sales of GPCR derivative securities (2 lines, Form 4, code S).

Other insiders filing for Structure Therapeutics Inc. (GPCR)

How to read Form 4 transaction codes